Podcasts about patient outcomes

Brad Haupt, Vice President of Supply Chain at Monument Health, joins Bob Evans at Workday Rising to discuss how the health system is modernizing operations through Workday's unified platform. He shares how consolidating 17 systems into Workday created a single source of truth for finance, HR, and supply chain data. By pairing data intelligence with a culture of innovation, Monument Health is transforming supply chain management from a behind-the-scenes function into a strategic driver of better healthcare experiences.AI and the New Healthcare Supply ChainThe Big Themes:Monument Health's Unique Challenges and Resilience: Located in remote western South Dakota, Monument Health faces the dual challenges of geographic isolation and sudden population surges during events like the Sturgis Motorcycle Rally. Haupt described how this environment demands both meticulous planning and quick adaptability. The annual influx of visitors, tripling the local population, acts as a stress test for supply chain agility. These experiences have honed the team's crisis management skills.Linking Supply Chain Excellence to Patient Outcomes: Perhaps the most profound shift at Monument Health is redefining supply chain success through the “value equation”: patient, physician, and caregiver experiences and outcomes divided by cost. Haupt rejects the traditional view of supply chain as purely cost-focused. Sometimes the higher-cost item delivers greater patient value, improving safety or recovery time. By connecting financial, supply, and clinical data, Workday allows leaders to quantify this relationship.AI and Automation Redefining Contract Management: Haupt discussed Workday's integration of Evisort for contract lifecycle management as a game changer. Currently, supply contracts can take eight to twenty-four hours of total work spread over weeks. With AI-assisted redlining and learning-based automation, the process could be reduced to seconds. The system will eventually learn from user edits, producing increasingly personalized and accurate suggestions. Haupt sees this as freeing supply chain professionals from time-consuming legal reviews to focus on high-value work.The Big Quote: “I think we're monitoring over 2,000 items that are back-ordered or shipping delays coming from overseas, or manufactured delays. So, we have to constantly communicate with the physician so they don't go into a procedure and think, I've got it all planned out in my brain, and then they say, 'Hand me a 12 French ...,' and they don't have one, and they've got to change their whole treatment plan. So, that communication is really key. Workday has helped us really automate some of that."More from Brad Haupt and Workday:Connect with Brad on LinkedIn or learn more about Workday and healthcare. Visit Cloud Wars for more.

In this episode of Disruption/Interruption, host KJ sits down with Jim Foote, CEO and founder of First Ascent Biomedical. Jim shares his personal journey from technology executive to cancer care innovator, after his son’s diagnosis changed his life. Discover how he’s disrupting the status quo in oncology with AI-driven, personalized medicine that’s giving new hope to patients and families. Key Takeaways: The Problem with Standard Cancer Care [3:53]The standard of care treats patients as if they are the same, but everyone is unique. This approach works two-thirds of the time, but leaves one-third of patients with few options. Functional Precision Medicine [13:04]Jim’s company tests up to 152 FDA-approved drugs on a patient’s biopsy to find the most effective treatment, providing doctors with data-driven options tailored to each individual. AI and Technology are Transforming Oncology [28:05]Advances in AI, robotics, and cloud computing have converged, making personalized cancer treatment faster, more affordable, and more effective than ever before. Impact and Future Vision [26:51]Jim’s goal is for every cancer patient to receive individualized treatment from the moment of diagnosis, improving outcomes and reducing unnecessary side effects. Quote of the Show (14:40):“I literally have gone from trying and hoping to testing and choosing.” — Jim Foote Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Jim Foote: LinkedIn: http://www.linkedin.com/in/jim-foote Company Website: https://firstascentbiomedical.com/ How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

In this episode of the Periop Talk Podcast, host Hannah Campbell and guest Dr. Lisa Spruce explore Enhanced Recovery After Surgery (ERAS) — a patient-centered, evidence-based approach proven to shorten recovery times and reduce complications. They discuss the purpose, importance, and implementation of ERAS protocols, and how facilities can earn recognition through AORN's Center of Excellence in Surgical Safety: Enhanced Recovery After Surgery. Dr. Spruce shares her inspiration for developing the ERAS Guideline and offers practical insights on overcoming common challenges in implementation. Whether you're new to ERAS or preparing your facility for recognition, this episode provides essential guidance for improving patient outcomes and surgical safety.Have questions or looking for more information? We'd love to chat with you! Follow the link to reach out:  https://aornit.atlassian.net/servicedesk/customer/portal/54/group/199/create/674Support the showWelcome to the Periop Talk—your go-to podcast series where we examine the world of perioperative nursing.Episode after episode, we're bringing you professional tips, clinical wisdom, and personal stories that highlight the real world of perioperative nursing. Curious about the latest surgical techniques? We got you. Wondering how to navigate the challenges of the periop journey? We're here for that too.Our podcast series isn't just about sharing information; it's about building a community. Meet the people behind the masks, hear their journeys, and join the rotation of periop professionals making a difference. From students and new nurses to seasoned pros, we've got content for every stage of your perioperative practice.Periop Talk is your peek behind the red line to the world of perioperative nursing. It's not just about the OR – it's about the heart and soul of healthcare. Let's scrub in and start making surgery safer, one podcast at a time.Watch more episodes at: (1) Periop Talk vlog - YouTube

Dr. Kamal Golla, Vice President of Clinical Technologies and Performance at Evolent, highlights the complexities of cancer care and the need for care navigation to address medical, emotional, financial, and logistical challenges. This comprehensive approach leads to improved treatment adherence and patient satisfaction while reducing emergency room visits and hospitalization. The care team serves as an extension of the medical decision-makers, helping to manage care across multiple specialists, advising on overcoming side effects, and reducing logistical hurdles to ease the burden on physicians and caregivers, ultimately improving patient outcomes. Kamal explains, "Cancer care navigation is really about creating a roadmap for patients. It's making sure they're not left alone to piece together appointments, interpret side effects, or figure out how to pay for medications. The role of a navigator here is really to guide them through the whole journey. That includes the medical components that many folks are familiar with, but also the emotional, financial, and logistical components that come with a cancer diagnosis. The evidence is really clear, given that more than half of emergency department visits and nearly a quarter of hospitalizations related to cancer care are actually avoidable, that responding rapidly to these situations is key." "In our navigation program, we are rooted in patient-centric navigation, meaning we ask them what the transportation difficulties are that they might face. Who is your caregiver and their support? What do you do for work? What are your cultural and religious beliefs? All of those play a big part in dealing with the new diagnosis of cancer. We want all of that information to be able to provide a very personalized journey."  #Evolent #Oncology #CancerCare #CareNavigation #HealthcareInnovation #DigitalHealth #PersonalizedCare #PatientCenteredCare #Evolent #Careology Evolent.com Listen to the podcast here

Dr. Kamal Golla, Vice President of Clinical Technologies and Performance at Evolent, highlights the complexities of cancer care and the need for care navigation to address medical, emotional, financial, and logistical challenges. This comprehensive approach leads to improved treatment adherence and patient satisfaction while reducing emergency room visits and hospitalization. The care team serves as an extension of the medical decision-makers, helping to manage care across multiple specialists, advising on overcoming side effects, and reducing logistical hurdles to ease the burden on physicians and caregivers, ultimately improving patient outcomes. Kamal explains, "Cancer care navigation is really about creating a roadmap for patients. It's making sure they're not left alone to piece together appointments, interpret side effects, or figure out how to pay for medications. The role of a navigator here is really to guide them through the whole journey. That includes the medical components that many folks are familiar with, but also the emotional, financial, and logistical components that come with a cancer diagnosis. The evidence is really clear, given that more than half of emergency department visits and nearly a quarter of hospitalizations related to cancer care are actually avoidable, that responding rapidly to these situations is key." "In our navigation program, we are rooted in patient-centric navigation, meaning we ask them what the transportation difficulties are that they might face. Who is your caregiver and their support? What do you do for work? What are your cultural and religious beliefs? All of those play a big part in dealing with the new diagnosis of cancer. We want all of that information to be able to provide a very personalized journey."  #Evolent #Oncology #CancerCare #CareNavigation #HealthcareInnovation #DigitalHealth #PersonalizedCare #PatientCenteredCare #Evolent #Careology Evolent.com Download the transcript here

Matthew L. Goodwin, MD, PhD, FACSMSheng-fu Larry Lo, MD, MHSDaniel M. Sciubba, MD

Help eliminate hepatitis B with early detection, vaccination, and cutting-edge care. Credit available for this activity expires: 9/25/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/changing-game-hepatitis-b-care-breakthroughs-and-advances-2025a1000pez?ecd=bdc_podcast_libsyn_mscpedu

Show NotesWhy transitional care is at the heart of Your Health's modelHow incentives for early post-hospital visits worked (and why they didn't)Why in-person care matters more than telehealth aloneThe growing role of respiratory therapists, physical and occupational therapists, and community health workersThe challenge of patient perception: “too many visits” vs. “too many calls”Why insurance companies trying to become providers is dangerous for patientsScott's philosophy: nothing should be written in stone — adapt and evolveThe simple but powerful call to action for providers: “Go see your damn patients.” www.YourHealth.Org

Sam Libby is President and Managing Director of TCB Capital Advisors, a healthcare-focused investment and advisory firm with a focus on improving patient outcomes in oncology, neurodegenerative diseases, and women's health. The firm evaluates early-stage companies based on the strength of clinical data, scientific and medical expertise, and technology, which may have been overlooked or struggled to raise funding. Trends TCB is keeping an eye on include diagnostics and preventive healthcare, as well as the growing interest in women's health, an underinvested sector that presents significant opportunities for innovation and investment. Sam explains, "I think first and foremost, we look at the clinical data. So the way that we built TCD is that we have a team of experienced bankers and investors who work with early-stage companies. We also have on the other side of the house commercial experts and consultants who can do, I like to always say they can do all the things that bankers talk about. So, post-merger integration, building out the sales funnel, and applying for grants." "The other side, which I believe is probably the most important, is the scientific, strategic, and clinical advisory boards. And so when you're looking at one of these early-stage companies, the first thing is, does the science work? Is the actual foundation for the company solid? And so having experts that can drill into that because it's very easy when you start talking about deals and an early-stage company, everyone gets excited by the vision of the CEO or founder."  #TCBCapitalAdvisors #Healthcare #HeatlhcareInvestments #PatientOutcomes #Oncology #NeurodegenerativeDiseases #WomensHealth   TCBcapitaladvisors.com Download the transcript here

Sam Libby is President and Managing Director of TCB Capital Advisors, a healthcare-focused investment and advisory firm with a focus on improving patient outcomes in oncology, neurodegenerative diseases, and women's health. The firm evaluates early-stage companies based on the strength of clinical data, scientific and medical expertise, and technology, which may have been overlooked or struggled to raise funding. Trends TCB is keeping an eye on include diagnostics and preventive healthcare, as well as the growing interest in women's health, an underinvested sector that presents significant opportunities for innovation and investment. Sam explains, "I think first and foremost, we look at the clinical data. So the way that we built TCD is that we have a team of experienced bankers and investors who work with early-stage companies. We also have on the other side of the house commercial experts and consultants who can do, I like to always say they can do all the things that bankers talk about. So, post-merger integration, building out the sales funnel, and applying for grants." "The other side, which I believe is probably the most important, is the scientific, strategic, and clinical advisory boards. And so when you're looking at one of these early-stage companies, the first thing is, does the science work? Is the actual foundation for the company solid? And so having experts that can drill into that because it's very easy when you start talking about deals and an early-stage company, everyone gets excited by the vision of the CEO or founder."  #TCBCapitalAdvisors #Healthcare #HeatlhcareInvestments #PatientOutcomes #Oncology #NeurodegenerativeDiseases #WomensHealth   TCBcapitaladvisors.com Listen to the podcast here

If you were given some of the worst news in the world, wouldn't you expect your doctors to use every tool available?What if one of those tools could save millions of lives—and the science is already here?The world's largest medical cannabis and cancer study—10,000 papers, ranked in the top 5% globally—shows overwhelming evidence that cannabis has medical benefits. If fully embraced, its impact on patients and medicine could be transformative. As science continues to unfold, sometimes it takes skeptics to dive deep and uncover what's truly there, even when powerful interests push back.This week we sit down with Ryan Castle, Research Director at Whole Health Oncology Institute, to discuss:Medical cannabis: efficacy, placebo, and why it matters less than you thinkHow this study is being used in rescheduling effortsHow vested interests fuel anti-cannabis researchChapters00:00 Introduction to Medical Cannabis Research03:06 Ryan Castle's Journey into Cannabis Research05:58 The Meta-Analysis Process Explained09:00 Understanding the Data and Its Implications11:54 Skepticism and the Shift in Perspective15:01 Consensus in Medical Cannabis Research18:04 Nuances in Cancer Treatment and Cannabis20:55 Biomarkers and Inflammatory Responses22:56 Exploring Cannabis and Cancer Outcomes29:37 Bridging the Gap: Patient-Reported Outcomes35:32 The Future of Medical Cannabis Research45:34 The Cancer Playbook: Empowering Patients SummaryIn this episode, Bryan Fields and Kellan Finney engage with Ryan Castle, Research Director at Whole Health Oncology Institute, to explore the evolving landscape of medical cannabis research. Ryan shares his journey from skepticism to advocacy, detailing the extensive meta-analysis he conducted on the efficacy of cannabis in treating various symptoms and conditions, particularly in oncology. The conversation delves into the challenges of measuring effectiveness, the importance of patient-reported outcomes, and the need for a shift in medical perspectives towards cannabis as a legitimate treatment option. Ryan emphasizes the potential impact of policy changes and the importance of transparency in research, while also discussing the Cancer Playbook initiative aimed at empowering patients with data-driven insights. TakeawaysRyan Castle initially set out to prove that cannabis doesn't work.His extensive research revealed that cannabis is effective for a wide range of conditions.The meta-analysis included over 10,000 studies and 800,000 data points.Cannabis showed efficacy not just for symptoms but also for cancer treatment.Patient-reported outcomes are crucial for understanding cannabis effectiveness.The study found that cannabis can help reduce opioid dependency.There is a significant need for a shift in medical perspectives on cannabis.Transparency in research is essential for building trust in findings.The health impact assessment could reveal the broader benefits of cannabis.The Cancer Playbook initiative aims to empower patients with data-driven insights.Guest Linkshttps://wholehealthoncologyinstitute.com/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.

Do you really think 60–80% success rates over 2 weeks to 8 months is successful? I don't.In this episode of the Unreal Results podcast, I answer a great question someone recently asked me in the Missing Link Facebook group: what are my success rates? I break down why I think the industry average doesn't cut it, and why I confidently guarantee results in just 1–3 visits.I also dig into what “success” actually means, why context and nuance matter, and how clarity in assessment can shift outcomes, sharing real-life cases from pro athletes to clients with complex, long-haul health issues.If you're tired of mediocre results being considered “normal,” this episode will give you a fresh perspective on what's possible for your clients and for you as a clinician.Resources Mentioned In This EpisodeJoin the waitlist for the 2025 online LTAP™ LEVEL 1 course HERE!Episode 42: The Fundamental Attribution Error and Why You May be the Problem, Not Your ClientEpisode 119: Guaranteeing Results... Until You Can'tEpisode 126: How Many Sessions Do Clients Really Need?Learn the LTAP™ In-Person in one of my upcoming coursesConsidering the viscera as a source of musculoskeletal pain and dysfunction is a great way to ensure a more true whole body approach to care, however it can be a bit overwhelming on where to start, which is exactly why I created the Visceral Referral Cheat Sheet. This FREE download will help you to learn the most common visceral referral patterns affecting the musculoskeletal system. Download it at www.unrealresultspod.com=================================================Watch the podcast on YouTube and subscribe!Join the MovementREV email list to stay up to date on the Unreal Results Podcast and MovementREV education. Be social and follow me:Instagram | Facebook | Twitter | YouTube

SLP fear is real, but facts are louder. In this Fix SLP Podcast episode, Dr. Jeanette Benigas, SLP, and Preston Lewis, MS/SLP, unpack the top fears heard daily: Praxis retakes, reinstating the ASHA CCC, supervision requirements, getting overlooked by misinformed employers, whether CCC status affects international portability via the Mutual Recognition Agreement (MRA) with the UK, Canada, Ireland, Australia, and New Zealand, and how employer education, not court battles, drives SLP autonomy and better jobs.This episode shows how to turn fear into facts: evaluating your local job market, approaching HR about removing CCC requirements, clarifying supervision rules, and proving that patient outcomes, not extra letters, define true competence in the field.Thank you to our sponsor, ⭐️ Informed Jobs, ⭐️ connecting SLPs with meaningful job opportunities and career resources to keep you informed and empowered. Explore more at informedslp.com. Just click the menu, then select "Jobs"!

Osteosarcoma Webinar Series: Yanding Zhao, PhD to discuss how Distinct patterns of chromosomal instability fuel osteosarcoma progression and influence patient outcomes.Osteosarcoma (OS) is notable for extreme chromosomal instability (CIN) and molecular heterogeneity, which have hindered therapeutic progress. To address this, the lab performed longitudinal and multi-modal profiling of 91 tumors from 71 pediatric patients, integrating whole-genome and transcriptome sequencing with ATAC-seq and Hi-C in matched cell lines. Their analyses revealed that key driver mutations, including TP53, are fixed early and persist through progression. Over 80% of tumors exhibited complex structural alterations—such as chromothripsis, kataegis, loss of heterozygosity, and ecDNA amplification—with MYC enhancer hijacking linked to chemoresistance. They identified a high-risk evolutionary trajectory marked by homologous recombination deficiency (HRD)-like signatures in the absence of BRCA mutations. These tumors showed focal duplications at fragile sites, early whole-genome doubling, high TP53 mutation burden, and sensitivity to PARP inhibition—highlighting a potential therapeutic vulnerability. Together, these findings define a replication stress–driven model of OS evolution, shaped by early chromosomal remodeling and ecDNA-mediated oncogene activation, with implications for biomarker development and precision treatment strategies.Dr. Yanding Zhao is a postdoctoral researcher at Stanford University in the lab of Dr. Christina Curtis. He earned his PhD in Genetics from Dartmouth College, where he began developing computational tools to understand how genome instability disrupts gene regulation in cancer. At Stanford, his research focuses on pediatric osteosarcoma. By combining genome sequencing, 3D chromatin mapping, and spatial transcriptomics, he studies how tumors evolve, resist treatment, and evade the immune system. Dr. Zhao works closely with clinicians and scientists to help turn these discoveries into potential new therapies. He is honored to be part of the MIB Agents community and looks forward to sharing his work in a way that resonates with patients, families, and advocates.

En este episodio exploramos a fondo el mutismo acinético, una de las manifestaciones más desconcertantes tras un daño cerebral grave. Hablamos de su base neurofisiológica, su relación con el sistema dopaminérgico y los circuitos prefronto-subcorticales, y cómo se diferencia clínicamente de otros estados de conciencia alterada. Recorremos también las opciones terapéuticas más prometedoras, desde la estimulación multisensorial y la verticalización robótica hasta técnicas de neuromodulación como la estimulación cerebral profunda, la estimulación medular o la tDCS. Un episodio técnico, narrativo y lleno de preguntas clínicas clave, pensado para quienes trabajan día a día con pacientes que aún no responden... pero que podrían hacerlo. Referencias del episodio: 1. Arnts, H., van Erp, W. S., Lavrijsen, J. C. M., van Gaal, S., Groenewegen, H. J., & van den Munckhof, P. (2020). On the pathophysiology and treatment of akinetic mutism. Neuroscience and biobehavioral reviews, 112, 270–278. https://doi.org/10.1016/j.neubiorev.2020.02.006 8 https://pubmed.ncbi.nlm.nih.gov/32044373/). 2. Arnts, H., Tewarie, P., van Erp, W. S., Overbeek, B. U., Stam, C. J., Lavrijsen, J. C. M., Booij, J., Vandertop, W. P., Schuurman, R., Hillebrand, A., & van den Munckhof, P. (2022). Clinical and neurophysiological effects of central thalamic deep brain stimulation in the minimally conscious state after severe brain injury. Scientific reports, 12(1), 12932. https://doi.org/10.1038/s41598-022-16470-2 (https://pubmed.ncbi.nlm.nih.gov/35902627/). 3. Arnts, H., Tewarie, P., van Erp, W., Schuurman, R., Boon, L. I., Pennartz, C. M. A., Stam, C. J., Hillebrand, A., & van den Munckhof, P. (2024). Deep brain stimulation of the central thalamus restores arousal and motivation in a zolpidem-responsive patient with akinetic mutism after severe brain injury. Scientific reports, 14(1), 2950. https://doi.org/10.1038/s41598-024-52267-1 (https://pubmed.ncbi.nlm.nih.gov/38316863/). 4. Bai, Y., Xia, X., Li, X., Wang, Y., Yang, Y., Liu, Y., Liang, Z., & He, J. (2017). Spinal cord stimulation modulates frontal delta and gamma in patients of minimally consciousness state. Neuroscience, 346, 247–254. https://doi.org/10.1016/j.neuroscience.2017.01.036 (https://pubmed.ncbi.nlm.nih.gov/28147246/). 5. Bai, Y., Xia, X., Liang, Z., Wang, Y., Yang, Y., He, J., & Li, X. (2017). Corrigendum: Frontal Connectivity in EEG Gamma (30-45 Hz) Respond to Spinal Cord Stimulation in Minimally Conscious State Patients. Frontiers in cellular neuroscience, 11, 251. https://doi.org/10.3389/fncel.2017.00251 (https://pubmed.ncbi.nlm.nih.gov/28828002/). 6. Bai, Y., Lin, Y., & Ziemann, U. (2021). Managing disorders of consciousness: the role of electroencephalography. Journal of neurology, 268(11), 4033–4065. https://doi.org/10.1007/s00415-020-10095-z (https://pubmed.ncbi.nlm.nih.gov/32915309/). 7. Cairns, H., Oldfield, R. C., Pennybacker, J. B., & Whitteridge, D. (1941). Akinetic mutism with an epidermoid cyst of the 3rd ventricle. Brain, 64(4), 273–290 (https://academic.oup.com/brain/article-abstract/64/4/273/332088?redirectedFrom=fulltext). 8. Chen, Q., Huang, W., Tang, J., Ye, G., Meng, H., Jiang, Q., Ge, L., Li, H., Liu, L., Jiang, Q., & Wang, D. (2025). Reviving consciousness: The impact of short-term spinal cord stimulation on patients with early-onset prolonged disorders of consciousness. Journal of Neurorestoratology, 13(1), 100143. https://doi.org/10.1016/j.jnrt.2024.100143 (https://www.sciencedirect.com/science/article/pii/S2324242624000500?via%3Dihub). 9. Clavo, B., Robaina, F., Montz, R., Carames, M. A., Otermin, E., & Carreras, J. L. (2008). Effect of cervical spinal cord stimulation on cerebral glucose metabolism. Neurological research, 30(6), 652–654. https://doi.org/10.1179/174313208X305373 (https://pubmed.ncbi.nlm.nih.gov/18513465/). 10. Corazzol, M., Lio, G., Lefevre, A., Deiana, G., Tell, L., André-Obadia, N., Bourdillon, P., Guenot, M., Desmurget, M., Luauté, J., & Sirigu, A. (2017). Restoring consciousness with vagus nerve stimulation. Current biology : CB, 27(18), R994–R996. https://doi.org/10.1016/j.cub.2017.07.060 (https://pubmed.ncbi.nlm.nih.gov/28950091/). 11. Della Pepa, G. M., Fukaya, C., La Rocca, G., Zhong, J., & Visocchi, M. (2013). Neuromodulation of vegetative state through spinal cord stimulation: where are we now and where are we going?. Stereotactic and functional neurosurgery, 91(5), 275–287. https://doi.org/10.1159/000348271 (https://pubmed.ncbi.nlm.nih.gov/23797266/). 12. De Luca, R., Bonanno, M., Vermiglio, G., Trombetta, G., Andidero, E., Caminiti, A., Pollicino, P., Rifici, C., & Calabrò, R. S. (2022). Robotic Verticalization plus Music Therapy in Chronic Disorders of Consciousness: Promising Results from a Pilot Study. Brain sciences, 12(8), 1045. https://doi.org/10.3390/brainsci12081045 (https://pubmed.ncbi.nlm.nih.gov/36009107/). 13. Dong, X., Tang, Y., Zhou, Y., & Feng, Z. (2023). Stimulation of vagus nerve for patients with disorders of consciousness: a systematic review. Frontiers in neuroscience, 17, 1257378. https://doi.org/10.3389/fnins.2023.1257378 (https://pubmed.ncbi.nlm.nih.gov/37781261/). 14. Fan, W., Fan, Y., Liao, Z., & Yin, Y. (2023). Effect of Transcranial Direct Current Stimulation on Patients With Disorders of Consciousness: A Systematic Review and Meta-analysis. American journal of physical medicine & rehabilitation, 102(12), 1102–1110. https://doi.org/10.1097/PHM.0000000000002290 (https://pubmed.ncbi.nlm.nih.gov/37205736/). 15. Frazzitta, G., Zivi, I., Valsecchi, R., Bonini, S., Maffia, S., Molatore, K., Sebastianelli, L., Zarucchi, A., Matteri, D., Ercoli, G., Maestri, R., & Saltuari, L. (2016). Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: A Randomized Pilot Study in ICU. PloS one, 11(7), e0158030. https://doi.org/10.1371/journal.pone.0158030 (https://pubmed.ncbi.nlm.nih.gov/27447483/). 16. Jang, S. H., & Byun, D. H. (2022). A Review of Studies on the Role of Diffusion Tensor Magnetic Resonance Imaging Tractography in the Evaluation of the Fronto-Subcortical Circuit in Patients with Akinetic Mutism. Medical science monitor : international medical journal of experimental and clinical research, 28, e936251. https://doi.org/10.12659/MSM.936251 (https://pubmed.ncbi.nlm.nih.gov/35181647/). 17. Lombardi, F., Taricco, M., De Tanti, A., Telaro, E., & Liberati, A. (2002). Sensory stimulation for brain injured individuals in coma or vegetative state. The Cochrane database of systematic reviews, 2002(2), CD001427. https://doi.org/10.1002/14651858.CD001427 (https://pmc.ncbi.nlm.nih.gov/articles/PMC7045727/). 18. Magee, W. L., & O'Kelly, J. (2015). Music therapy with disorders of consciousness: current evidence and emergent evidence-based practice. Annals of the New York Academy of Sciences, 1337, 256–262. https://doi.org/10.1111/nyas.12633 (https://pubmed.ncbi.nlm.nih.gov/25773642/). 19. Mateo-Sierra, O., Gutiérrez, F.A., Fernández-Carballal, C., Pinilla, D., Mosqueira, B., Iza, B., & Carrillo, R.. (2005). Mutismo acinético relacionado con hidrocefalia y cirugía cerebelosa tratado con bromocriptina y efedrina: revisión fisiopatológica. Neurocirugía, 16(2), 134-141. (https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-14732005000200005). 20. Noé, E., Ferri, J., Colomer, C., Moliner, B., O'Valle, M., Ugart, P., Rodriguez, C., & Llorens, R. (2020). Feasibility, safety and efficacy of transauricular vagus nerve stimulation in a cohort of patients with disorders of consciousness. Brain stimulation, 13(2), 427–429. https://doi.org/10.1016/j.brs.2019.12.005 (https://pubmed.ncbi.nlm.nih.gov/31866491/). 21. Norwood, M. F., Lakhani, A., Watling, D. P., Marsh, C. H., & Zeeman, H. (2023). Efficacy of Multimodal Sensory Therapy in Adult Acquired Brain Injury: A Systematic Review. Neuropsychology review, 33(4), 693–713. https://doi.org/10.1007/s11065-022-09560-5 (https://pubmed.ncbi.nlm.nih.gov/36056243/). 22. O'Neal, C. M., Schroeder, L. N., Wells, A. A., Chen, S., Stephens, T. M., Glenn, C. A., & Conner, A. K. (2021). Patient Outcomes in Disorders of Consciousness Following Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Individual Patient Data. Frontiers in neurology, 12, 694970. https://doi.org/10.3389/fneur.2021.694970 (https://pubmed.ncbi.nlm.nih.gov/34475848/). 23. Schiff, N. D., Giacino, J. T., Kalmar, K., Victor, J. D., Baker, K., Gerber, M., Fritz, B., Eisenberg, B., Biondi, T., O'Connor, J., Kobylarz, E. J., Farris, S., Machado, A., McCagg, C., Plum, F., Fins, J. J., & Rezai, A. R. (2007). Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature, 448(7153), 600–603. https://doi.org/10.1038/nature06041 (https://pubmed.ncbi.nlm.nih.gov/17671503/). 24. Schiff N. D. (2016). Central thalamic deep brain stimulation to support anterior forebrain mesocircuit function in the severely injured brain. Journal of neural transmission (Vienna, Austria : 1996), 123(7), 797–806. https://doi.org/10.1007/s00702-016-1547-0 (https://pubmed.ncbi.nlm.nih.gov/27113938/). 25. Schiff N. D. (2023). Mesocircuit mechanisms in the diagnosis and treatment of disorders of consciousness. Presse medicale (Paris, France : 1983), 52(2), 104161. https://doi.org/10.1016/j.lpm.2022.104161 (https://pubmed.ncbi.nlm.nih.gov/36563999/). 26. Shimojo, S., & Shams, L. (2001). Sensory modalities are not separate modalities: plasticity and interactions. Current opinion in neurobiology, 11(4), 505–509. https://doi.org/10.1016/s0959-4388(00)00241-5 (https://pubmed.ncbi.nlm.nih.gov/11502399/). 27. Stephens, T. M., Young, I. M., O'Neal, C. M., Dadario, N. B., Briggs, R. G., Teo, C., & Sughrue, M. E. (2021). Akinetic mutism reversed by inferior parietal lobule repetitive theta burst stimulation: Can we restore default mode network function for therapeutic benefit?. Brain and behavior, 11(8), e02180. https://doi.org/10.1002/brb3.2180 (https://pubmed.ncbi.nlm.nih.gov/34145791/). 28. Piedade, G. S., Assumpcao de Monaco, B., Guest, J. D., & Cordeiro, J. G. (2023). Review of spinal cord stimulation for disorders of consciousness. Current opinion in neurology, 36(6), 507–515. https://doi.org/10.1097/WCO.0000000000001222 (https://pubmed.ncbi.nlm.nih.gov/37889524/). 29. Rosenfelder, M. J., Helmschrott, V. C., Willacker, L., Einhäupl, B., Raiser, T. M., & Bender, A. (2023). Effect of robotic tilt table verticalization on recovery in patients with disorders of consciousness: a randomized controlled trial. Journal of neurology, 270(3), 1721–1734. https://doi.org/10.1007/s00415-022-11508-x (https://pubmed.ncbi.nlm.nih.gov/36536249/). 30. Thibaut, A., Bruno, M. A., Ledoux, D., Demertzi, A., & Laureys, S. (2014). tDCS in patients with disorders of consciousness: sham-controlled randomized double-blind study. Neurology, 82(13), 1112–1118. https://doi.org/10.1212/WNL.0000000000000260 (https://pubmed.ncbi.nlm.nih.gov/24574549/). 31. Visocchi, M., Della Pepa, G. M., Esposito, G., Tufo, T., Zhang, W., Li, S., & Zhong, J. (2011). Spinal cord stimulation and cerebral hemodynamics: updated mechanism and therapeutic implications. Stereotactic and functional neurosurgery, 89(5), 263–274. https://doi.org/10.1159/000329357 (https://pubmed.ncbi.nlm.nih.gov/21860253/). 32. Yang, Y., He, Q., Xia, X., Dang, Y., Chen, X., He, J., & Zhao, J. (2022). Long-term functional prognosis and related factors of spinal cord stimulation in patients with disorders of consciousness. CNS neuroscience & therapeutics, 28(8), 1249–1258. https://doi.org/10.1111/cns.13870 (https://pubmed.ncbi.nlm.nih.gov/35619213/). 33. Yang, Y., He, Q., Dang, Y., Xia, X., Xu, X., Chen, X., Zhao, J., & He, J. (2023). Long-term functional outcomes improved with deep brain stimulation in patients with disorders of consciousness. Stroke and vascular neurology, 8(5), 368–378. https://doi.org/10.1136/svn-2022-001998 (https://pubmed.ncbi.nlm.nih.gov/36882201/). 34. Yu, Y. T., Yang, Y., Wang, L. B., Fang, J. L., Chen, Y. Y., He, J. H., & Rong, P. J. (2017). Transcutaneous auricular vagus nerve stimulation in disorders of consciousness monitored by fMRI: The first case report. Brain stimulation, 10(2), 328–330. https://doi.org/10.1016/j.brs.2016.12.004 (https://pubmed.ncbi.nlm.nih.gov/28017322/). 35. Zhou, Y. F., Kang, J. W., Xiong, Q., Feng, Z., & Dong, X. Y. (2023). Transauricular vagus nerve stimulation for patients with disorders of consciousness: A randomized controlled clinical trial. Frontiers in neurology, 14, 1133893. https://doi.org/10.3389/fneur.2023.1133893 (https://pubmed.ncbi.nlm.nih.gov/36937511/). 36. Zhuang, Y., Yang, Y., Xu, L., Chen, X., Geng, X., Zhao, J., & He, J. (2022). Effects of short-term spinal cord stimulation on patients with prolonged disorder of consciousness: A pilot study. Frontiers in neurology, 13, 1026221. https://doi.org/10.3389/fneur.2022.1026221 (https://pubmed.ncbi.nlm.nih.gov/36313512/). 37. Zuo, J., Tao, Y., Liu, M., Feng, L., Yang, Y., & Liao, L. (2021). The effect of family-centered sensory and affective stimulation on comatose patients with traumatic brain injury: A systematic review and meta-analysis. International journal of nursing studies, 115, 103846. https://doi.org/10.1016/j.ijnurstu.2020.103846 (https://pubmed.ncbi.nlm.nih.gov/33485101/).

Scaling spinal decompression doesn't have to be complicated. Dr. Pete sits down with Dr. Chad Glines and Dr. Caleb Braddock of Genesis Back & Neck you'll hear how two chiropractors grew from one clinic to more than 70 by sticking to a simple, principled model built on the DRX9000, clear systems, and strong partnerships. They share how disc patients need a different approach, why one protocol beats constant tweaking, and how the right structure can create freedom, consistency, and predictable outcomes for doctors and patients.In this episode you will:Learn how to pair clinical excellence with systems that scaleUnderstand why disc patients require a different communication styleSee how one machine and one protocol can standardize resultsIdentify the traits of partners who succeed quickly versus those who stallDiscover a cash-based model that drives both impact and freedom Episode Highlights01:32 – How Dr. Caleb and Dr. Chad came together to serve disc patients with a new model03:17 – Why disc cases were the hardest to manage with traditional chiropractic care04:21 – The origin of Genesis and how combining systems with decompression created a breakthrough05:30 – The first expansion and how one partnership grew into 70 offices in 26 states07:13 – Forming the partnership quickly and the unique challenges of merging practices08:25 – Why disc patients require a completely different consultation and ROF09:12 – Discovering Genesis as a principled decompression business aligned with chiropractic values11:21 – Why seasoned chiropractors with established offices are the best partners12:42 – Referral-based growth and why alignment matters more than advertising14:54 – Defining success by aligning vision, values, and behaviors16:01 – Identifying ideal partners who are coachable and ready for a proven recipe17:30 – Why Genesis insists on one machine and one protocol for predictable outcomes23:07 – The DRX9000 advantage and why true decompression differs from traction24:27 – Building confidence through results and standardized care protocols26:35 – Plug-and-play systems that save time and act like a “comfort blanket”27:20 – The “do it stupid” concept and how overthinking stalls success28:51 – A success story: multiple months at $100K+ from decompression services31:05 – Trends in chiropractic and why Genesis is built to outlast fads33:18 – Disc herniation as a growing problem that requires mechanical solutions34:24 – Long-term stability and why decompression offers lasting impact for practices37:25 - Dr. Malcolm is joined by Success Partner, Sam Ogutucu, founder of Medic Cloud, who shares how his company helps chiropractors streamline IT infrastructure and X-ray systems for efficient, scalable growth. Medic Cloud optimizes clinic launches, automates workflows, and integrates cost-effective X-ray solutions to maximize efficiency and ROI. Discover how their innovative tech solutions enhance operations, reduce costs, and support seamless practice growth. Resources MentionedJoin the TRP Remarkable Attraction Immersion - Oct 10 and 11 in Phoenix, AZ and Oct 24 & 25 in Adelaide, AUS - https://theremarkablepractice.com/upcoming-events/For more information about Medic Cloud please visit:  https://mediccloud.com.au/Schedule a Strategy Call with Dr. Pete - https://go.oncehub.com/PodcastPCPrefer to watch? Catch the podcast on YouTube at: https://www.youtube.com/@TheRemarkablePractice1To listen to more episodes, visit https://theremarkablepractice.com/podcastor follow on your favorite podcast app.

In this episode, our guest is Sam Libby, President and Managing Director of TCB Capital Advisors. Sam's long-standing career in healthcare investment banking has seen him lead over 30 impactful transactions, totaling more than $20 billion. His dedication to healthcare is rooted in a personal connection, being the son of two therapists, which has given him a unique understanding of the sector's challenges, particularly around patient access and care quality.As co-founder of TCB Capital Advisors, Sam focuses on empowering forward-thinking healthcare companies. His work spans partnerships with companies in oncology, neurodegenerative diseases, women's health, and digital health, helping to steer innovations that profoundly improve patient outcomes. Sam, welcome to the Talk to Your Pharmacist podcast. Now that our listeners have heard a bit about your background maybe you can fill in any gaps to that intro and share a bit about your personal life.Topics to discuss –Background & CareerSam, you've had an incredibly successful career in healthcare investment banking, leading over 30 transactions totaling more than $20 billion. Can you walk us through how you first became interested in the healthcare sector, and how your upbringing as the son of two therapists shaped your perspective on healthcare?As co-founder of TCB Capital Advisors, how did you identify the unique opportunity to focus specifically on healthcare companies? What challenges did you face in the early days of building your firm?Healthcare Investment LandscapeYou've been involved in transactions across diverse areas, such as oncology, neurodegenerative diseases, women's health, and digital health. How do you assess which healthcare innovations and companies are worth investing in? What are some key trends you're seeing in these sectors today?Healthcare investment banking involves navigating both financial and clinical challenges. How do you balance the business side of healthcare with the real-world impact on patient access and care quality?You've been part of some transformative partnerships in healthcare. Can you share a specific example of a partnership that particularly stands out to you, both in terms of financial success and its impact on patient outcomes?Healthcare Innovation & StrategyWith your experience empowering forward-thinking healthcare companies, how do you foresee digital health and technology playing a larger role in the future of patient care? What do you think are the biggest opportunities and challenges?Women's health is one of the key sectors you've focused on. What are some innovations or initiatives you've seen that are making a real difference for women's healthcare, and how can investors further support these efforts?In your opinion, what role does patient access play in the broader healthcare investment landscape? How can companies balance innovation with the need to make these innovations accessible to all patients, especially underserved populations?Financial Strategies & Healthcare CompaniesHealthcare investments often involve complex financial strategies. For our audience who might not be familiar with the intricacies of healthcare investment banking, can you explain how financial strategies differ when working with healthcare companies as opposed to other industries?As a leader in healthcare investment banking, how do you guide companies through challenges like market volatility, regulatory hurdles, and competition in their efforts to innovate and grow? Are there any specific strategies you use to help them thrive?Future OutlookYou've helped shape the growth of companies across a wide range of therapeutic areas. Looking ahead, what sectors or healthcare innovations do you believe have the most potential to revolutionize patient outcomes in the next 5 to 10 years?As someone deeply involved in healthcare strategy and innovation, what advice would you give to young entrepreneurs or companies just starting to navigate the healthcare sector? What are the key lessons you've learned along the way?Lastly, what excites you most about the future of healthcare, and where do you see the biggest areas for disruption and opportunity?Guest - Sam Libby, TCB Capital AdvisorsHost - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

You use ketamine. I use ketamine. We all use ketamine. But… how safe it is, really? A new study out of Toronto suggests 30% of patients who receive ketamine have adverse events, a rate higher than seen in the ED. What are we to make of this? I bring Dr Remle Crowe on to discuss…Citations:1.     Kwong JL, Verbeek PR, Leong YC, Turner L, Huiskamp M, Drennan IR, Francom S, Ropp S, Cheskes S: Paramedic use of ketamine for severe agitation and violence. Can J Emerg Med. doi: 10.1007/s43678-025-00963-w (Epub ahead of print).2.     Fernandez AR, Bourn SS, Crowe RP, Bronsky ES, Scheppke KA, Antevy P, Myers JB: Out-of-Hospital Ketamine: Indications for Use, Patient Outcomes, and Associated Mortality. Annals of Emergency Medicine. 2021;78(1):123–31.3.     Brown LH, Crowe RP, Pepe PE, Miller ML, Watanabe BL, Kordik SS, Wampler DA, Page DI, Fernandez AR, Bourn SS, et al.: Adverse events following emergent prehospital sedation of patients with behavioral emergencies: A retrospective cohort study. The Lancet Regional Health - Americas. 2022;May;9:100183.

Dry eye management continues to be one of the most important areas in optometry today, impacting nearly every patient who walks into the exam lane. While treatments continue to evolve, one of the greatest tools eye care professionals can leverage is education, helping patients understand the daily habits, products, and risks that affect their ocular […]

This recording features audio versions of September 2025 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Interventional Radiology Reporting Standards and Checklist for Artificial Intelligence Research Evaluation (iCARE) ReadPreservation of Fertility by Direct Puncture Embolization of Acquired Uterine Arteriovenous Fistulae in Women of Childbearing Age with Life-Threatening Hemorrhage ReadMagnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: A prospective Trial ReadSafety and Effectiveness of Percutaneous Electrohydraulic and Laser Lithotripsy in the Management of Biliary Stones: The Multicenter National Percutaneous Cholangioscopy Registry ReadDegradable Starch Microsphere Transarterial Chemoembolization as Salvage Therapy in Patients with Uveal Melanoma Liver Metastases ReadHigh-Dose Radioembolization Limited by Lung Shunt for Hepatocellular Carcinoma Supplied by the Inferior Phrenic Artery ReadImpact of Hemodialysis Duration on Arterial Characteristics and Patient Outcomes following Endovascular Therapy for Inframalleolar Occlusive Disease: Results from the MAVERICK Study ReadJVIR and SIR thank all those who helped record this episode. To sign up to help with future episodes, please contact our outreach coordinator at millennie.chen.jvir@gmail.com.Host· Sonya Choe, University of California Riverside School of MedicineAudio Editor· Daniel Roh, Loma Linda University School of MedicineOutreach Coordinator:· Millennie Chen, University of California Riverside School of MedicineAbstract Readers:· Sakeena Siddiq, Western University of Health Sciences, California· Tiffany Nakla, Touro University Nevada College of Osteopathic Medicine, Nevada· Mark Oliinik, Loma Linda University School of Medicine· Nate Wright, Warren Alpert Medical School of Brown University· Daniel Roh,  Loma Linda University School of Medicine· Morgan Smeltzer, Western Michigan University Homer Stryker MD School of Medicine· Thanmayi Parasu, University of Texas Medical Branch Read more about interventional radiology in IR Quarterly magazine or SIR's Patient Center.Support the show Support the show

Resorbable embolics are gaining traction in musculoskeletal interventions, but what are the key technical considerations? Dr. Keerthi Prasad, interventional radiologist at the Centers for Pain Control and Vein Care joins host Dr. Ally Baheti to share practical insights when using resorbable embolics in MSK interventions.---This podcast is supported by:OBL Marketinghttps://www.oblmarketing.com---SYNPOSISDr. Prasad opens the conversation with an overview of embolic agents used in MSK interventions—including Imipenem, Lipiodol, and Nexsphere-F—and shares practical insights into technique selection. He explores the nuances of working with various resorbable embolics, highlighting clinical cases from his personal experience. The discussion also highlights Dr. Prasad's innovative approach to establishing an outpatient-based lab (OBL) focused on musculoskeletal interventions. Additionally, Dr. Prasad also offers insight into the expanding role of resorbable embolics in treating conditions such as knee arthritis, plantar fasciitis, and adhesive capsulitis. The episode ends with a call to broaden access to this evolving treatment.---TIMESTAMPS00:00 - Introduction01:55 - Outpatient Embolization and MSK Procedures04:20 - Resorbable Embolics in Joint Embolization04:52 - Available Resorbable Embolics in the US07:57 - Technical Insights on Using Resorbable Embolics15:18 - Patient Outcomes and Long-Term Durability22:24 - Future of MSK Embolization Techniques24:05 - Exploring New Applications for Resorbable Embolics27:30 - Innovative Procedures and Techniques37:00 - Final Thoughts and Advice for Practitioners

Resorbable embolics are gaining traction in musculoskeletal interventions, but what are the key technical considerations? Dr. Keerthi Prasad, interventional radiologist at the Centers for Pain Control and Vein Care joins host Dr. Ally Baheti to share practical insights when using resorbable embolics in MSK interventions.---This podcast is supported by:Medtronic OsteoCoolhttps://www.medtronic.com/en-us/healthcare-professionals/products/surgical-energy/ablation/radiofrequency-ablation/systems/osteocool-2-0-bone-tumor-ablation-system.html---SYNPOSISDr. Prasad opens the conversation with an overview of embolic agents used in MSK interventions—including Imipenem, Lipiodol, and Nexsphere-F—and shares practical insights into technique selection. He explores the nuances of working with various resorbable embolics, highlighting clinical cases from his personal experience. The discussion also highlights Dr. Prasad's innovative approach to establishing an outpatient-based lab (OBL) focused on musculoskeletal interventions. Additionally, Dr. Prasad also offers insight into the expanding role of resorbable embolics in treating conditions such as knee arthritis, plantar fasciitis, and adhesive capsulitis. The episode ends with a call to broaden access to this evolving treatment.---TIMESTAMPS00:00 - Introduction01:55 - Outpatient Embolization and MSK Procedures04:20 - Resorbable Embolics in Joint Embolization04:52 - Available Resorbable Embolics in the US07:57 - Technical Insights on Using Resorbable Embolics15:18 - Patient Outcomes and Long-Term Durability22:24 - Future of MSK Embolization Techniques24:05 - Exploring New Applications for Resorbable Embolics27:30 - Innovative Procedures and Techniques37:00 - Final Thoughts and Advice for Practitioners

An Otago University study has found a trauma service set up at Christchurch Hospital three years ago has failed to improve patient outcomes. Study author and surgeon Chris Wakeman spoke to Corin Dann.

Jaryd Bourke is a podiatrist and PhD candidate at Monash University Physiotherapy.  In this episode, Jaryd discusses Achilles tendinopathy and his research investigating heel lifts and changes in patient outcomes and biomechanics. Edit: Sorry for saying Wodonga is a city in NSW! At least I know people are listening...  it's on the border... Thanks to Jaryd for a great conversation. Use the timestamps below to jump to relevant sections. In this episode: 0:00 About this episode and welcome Jaryd 2:20 What is tendinopathy? 3:30 What is Achilles tendinopathy? 5:30 Heel lifts for Achilles tendinopathy - research 7:18 How could heel lifts help with Achilles tendinopathy symptoms 10:00 Jaryd's trial on heel lifts for Achilles tendinopathy – key methods 17:00 Clinical implications 23:33 Final thoughts Diagnostic domains, differential diagnosis and conditions requiring further medical attention that are considered important in the assessment for Achilles tendinopathy: a Delphi consensus study, link to paper:  https://bjsm.bmj.com/content/59/13/891.abstract Follow Jaryd on LinkedIn: https://www.linkedin.com/in/jaryd-bourke-86932b200/?originalSubdomain=au If you are finding this content helpful, we would appreciate a review and rating for the Physio Foundations podcast. This really helps promote the podcast to others. Hit the follow button and give us a review and 5-star rating. Stay connected: Read more at Perraton.Physio or the Perraton Physio LinkedIn page. Watch us on YouTube: https://www.youtube.com/@PerratonPhysio Follow @PerratonPhysio on Facebook, X (Twitter), Instagram and Linked In. This discussion is intended for health professionals and health professional students. Always seek guidance from a qualified health professional regarding any questions about your health or medical condition.

Story at-a-glance Vitamin D deficiency is widespread, especially in northern regions with limited sunlight. At Vibra Hospital in North Dakota, 44% of patients had dangerously low levels below 20 nanograms per milliliter (ng/mL) To correct vitamin D deficiency, Vibra Hospital implemented a structured vitamin D protocol that significantly improved patient recovery, reduced complications, and supported better overall outcomes Maintaining vitamin D levels between 60 and 80 ng/mL supports immune function, cardiovascular health, cognitive performance, hormone balance, and blood sugar regulation, as well as lowers risk of certain cancers Sun exposure is the most natural vitamin D source. Make sure to detox vegetable oils from your diet before spending time under peak sunlight hours, as they increase your risk of sunburn and skin damage If you need to take vitamin D3, start by testing your blood levels to find the right dose. Take it with a meal rich in healthy fats, and balance with magnesium and vitamin K2 to help your body absorb and use it properly

Send us a textWhat stands between hearing care professionals and effective advocacy? Dr. Megan Adams shatters common misconceptions with her doctoral research spanning 400 participants across the United States. The surprising truth? It's not time constraints holding us back...it's knowledge.Dr. Adams reveals that 95% of hearing healthcare professionals consider legislative issues crucial, and nearly 90% want greater involvement in advocacy efforts. They simply need the roadmap. This groundbreaking finding shifts our entire approach from convincing professionals to make time for advocacy to providing them with practical tools and education.Throughout our conversation, Dr. Adams dismantles the intimidation factor surrounding advocacy. Contrary to popular belief, most interactions with legislators don't involve debating policy but simply explaining what audiologists do and why quality hearing care matters. Small actions create tremendous impact—inviting officials to tour your clinic, hosting community events that include policymakers, or designating a team member to monitor relevant legislation during staff meetings.The power of state-level organization emerges as another critical theme. Dr. Adams highlights Indiana's new audiology coalition, which has already hosted a successful conference and is working toward hiring a lobbyist in its first year. These state organizations provide the collective voice needed to address potentially harmful legislation before it passes.Remember this fundamental truth: decisions affecting hearing healthcare will be made whether you participate or not. By educating policymakers and building community awareness, you ensure those decisions are informed by expertise rather than misconceptions. As Dr. Adams powerfully states, "I'm tired of playing defense. I want to play offense." Are you ready to join the movement transforming hearing healthcare advocacy from reactive to proactive? Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Twitter: @hearing_mattasFacebook: Hearing Matters Podcast

On this episode of Ditch the Lab Coat, Dr. Mark Bonta sits down with Dr. Georg Haymerle—once a top head and neck surgeon in Europe and Australia, now a dedicated advocate for culture change in medicine. Georg's journey is anything but typical: after reaching the pinnacle of surgical mastery, he made the radical decision to walk away—not because of burnout or failure, but to confront the invisible crisis unraveling healthcare teams from within.Join us as we dive into Dr. Haymerle's powerful story: from the grueling demands of 14-hour cancer surgeries and the accidental discovery of high-functioning, trust-based teams, to the moment when his own department's spirit collapsed under uncertainty. We'll explore why human factors like psychological safety and simple acts of gratitude can impact patient outcomes just as much as surgical skill. Dr. Haymerle takes us inside the often-overlooked world of healthcare team dynamics, revealing why he left the operating room behind to fix something even more delicate than anatomy: the fractured culture that shapes how care is delivered.If you've ever wondered whether culture truly matters in medicine—or how speaking up, vulnerability, and a heartfelt “thank you” might just save a life—this episode will stay with you long after you listen. Tune in for a heartfelt, evidence-based conversation about what really keeps healthcare teams—and their patients—thriving.Episode Highlights1. Team Spirit Transforms Outcomes — Cohesive, trusting teams dramatically improve surgical efficiency and patient safety, sometimes reducing surgery times by hours.2. Culture Changes Everything — Good workplace culture is just as critical as skill—loss of hope or toxic environments erode performance and morale.3. Technical Skill Isn't Enough — High technical mastery won't guarantee success if team dynamics and relationships are neglected or dysfunctional.4. Vulnerability Builds Excellence — When team members can safely show weaknesses and ask for help, everyone benefits, including patient outcomes.5. Money Isn't the Motivator — Financial rewards alone don't solve morale or performance issues; intrinsic motivators and appreciation matter more.6. Gratitude Is Powerful Medicine — Simple, genuine thank-yous are rare but transformative, fueling motivation, engagement, and mutual respect in healthcare teams.7. Speaking Up Saves Lives — Creating environments where all voices are heard—regardless of hierarchy—prevents errors and fosters innovation.8. Change Requires Leadership Buy-In — Cultural shifts succeed only when leaders acknowledge problems and model openness to feedback and improvement.9. Early Intervention Matters — Recognizing “the spiral” of team dysfunction early and addressing it promptly can prevent long-term damage and staff turnover.10. Healthcare Must Evolve — Emphasizing the human side of medicine—connection, gratitude, honest conversation—represents the future of safe, effective healthcare.Episode Timestamps03:58 — Career Shift in Healthcare Path06:41 — From Timid to Skilled Surgeon10:12 — Human Factors Impact Medical Outcomes14:33 — Creating a High-Performing Team19:10 — Building Trust for Departmental Progress22:37 — Surgical Trainee Silence Dilemma23:26 — Breaking Hierarchies: Encouraging Open Dialogue26:56 — Healthcare Organizations' Capacity for Change32:49 — Austrian Healthcare's Resistance to Change34:26 — Revolutionizing Healthcare Through Change37:54 — Targeting Female Leaders in HealthcareDISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.    Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

In this episode, recorded live at the 51st Academy Annual Meeting and Scientific Symposium in Atlanta, host Seth O'Brien, CP, FAAOP(D), welcomes Russ Lundstrom, Director of Clinical Research and Services at Ottobock and recipient of the Thranhardt Lecture Series Award. Lundstrom shares insights from his research on goal attainment and reduced reliance on walking aids, focusing on the use of real-world evidence alongside randomized controlled trials. The conversation explores the clinical impact of the C-Brace, including its influence on walking speed, fall reduction, and patient quality of life. Additional topics include goal setting, the value of individualized care, the role of physical therapy, and the importance of clinical judgment when introducing new technologies.   O&P Clinical Care Insiders is produced by Association Briefings. 

Learn about the importance of early intervention with on-demand therapies and the potential role of emerging therapies in bettering patient care.  Credit available for this activity expires: 3/7/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/hereditary-angioedema-headlines-early-intervention-2025a1000hj8?ecd=bdc_podcast_libsyn_mscpedu

Explore the future of healthcare in India with Vishal Lathwal, CEO of Apollo HomeCare. Uncover the booming Indian home healthcare market (projected to hit USD 64.4 Billion by 2033), a vital solution for hospital bed burden and high costs. Learn how Apollo HomeCare delivers integrated home healthcare services, including skilled nursing care, physiotherapy at home, post-operative care, and chronic disease management like diabetes and stroke recovery. Discover advanced medical technology enabling ECGs at home, X-rays at home, and remote patient monitoring, enhancing patient outcomes and family peace. Understand home healthcare costs in India (₹1,000-₹4,000/day, or ₹30,000-₹60,000+/month for caregivers/nurses) and challenges in health insurance coverage for domiciliary hospitalization. Discuss the impact of telemedicine, AI in healthcare, and wearable health technology on personalized care. Gain insights into career opportunities in home healthcare, driving a more compassionate society. Essential for those interested in elderly care, patient-centric healthcare, digital health solutions, and healthcare delivery models in India. Key Takeaways:✅ Massive growth of Indian home care market & its benefits.✅ Apollo HomeCare services, pricing, and health insurance coverage.✅ Impact of technology in home healthcare & career paths....#HomeHealthcare #IndiaHealthcare #ApolloHomeCare #HealthcareAtHome #PatientCare #HealthInsurance #MedicalCosts #ElderlyCare #ChronicDiseaseManagement #Telemedicine #DigitalHealth #AIinHealthcare #HealthcareInnovation #IndiaGrowthStory #HealthcareTrends #NursesAtHome #PhysiotherapyAtHome #PostOperativeCare #AffordableHealthcare #InvestingInHealth #IndianEconomySee omnystudio.com/listener for privacy information.

Modernizing Healthcare: How Cloud Adoption Drives Real Patient Outcomes On this episode, Jeremy Marut, Founder and CEO of Sublimation Health talks to host Ben Hilmes about how his decades of experience in hospital IT led him to build a company that helps health systems shift from managing infrastructure to delivering meaningful solutions. They explore what it takes to overcome fear and uncertainty around cloud migration, why cost transparency matters, and how to reframe technical debt as an opportunity for reinvention. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr. Jarratt Pytell stops by the show to discuss his recent article featured in the Journal of Addiction Medicine titled Post Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results - Article Link: Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results

How can multidisciplinary collaboration improve outcomes for your patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Discover expert strategies for optimal care.   Credit available for this activity expires: 6/26/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002602?ecd=bdc_podcast_libsyn_mscpedu

What if the key to transforming healthcare lies not in technology, but in presence, compassion, and purpose? In this rich conversation, Dr. Corey Anderson shares his journey into the "being movement" and how it's reshaping the culture at Black Hills Surgical Hospital. With wisdom drawn from his own transformation and collaborative work with Dr. Jeff Mars, Corey explores the profound shift from task-driven medicine to a human-centered model that prioritizes connection, empathy, and mission-driven care.Throughout the conversation, Corey and host Meredith Bell explore the ripple effects of this approach, from shorter hospital stays and deeper patient trust to more fulfilled healthcare workers. They discuss a new interpretation of Einstein's formula, E=MC², as a guide for healing through Mission, Compassion, and Competence. If you care about leading with purpose and creating meaningful change, you'll find inspiration and practical insight you can apply in your own work and life.About the Guest: Dr. Corey Anderson is a dynamic force in the healthcare landscape, whose mission is to unlock human potential, drive innovation, and foster a culture of collaboration and excellence. With a wealth of experience spanning Executive coaching, clinical expertise, operational leadership, and educational mentorship, Corey is a true trailblazer dedicated to transforming the way we think about healthcare systems, organizations, and workplace culture.Corey oversees a diverse line of healthcare services while championing a system-wide culture program focused on value-based leadership and coaching mindsets. His ability to integrate complex operations with a people-centered approach has earned him a reputation as an architect of sustainable change and growth. He has helped lead his hospital to the #1 Ranking in Major Orthopedic Surgery for three years in a row. From the operating room to the boardroom, and from academic settings to keynote stages, Dr. Corey Anderson is a visionary leader with a singular goal: to create systems and cultures that empower individuals, achieve excellence, and leave a lasting impact. The Being Group: https://systemofcreation.com/ Being in Medicine Website: https://beinginmedicine.com/ Being in Medicine Podcast: https://podcasts.apple.com/us/podcast/being-in-medicine-with-jeff-marrs-and-corey-anderson/id1817818295 YouTube: https://www.youtube.com/@BeingInMedicine LinkedIn: https://www.linkedin.com/in/corey-anderson-a39a4513a/ Facebook https://www.facebook.com/corey.anderson.5492 Black Hills Surgical Hospital https://bhsh.com/ Black Hills Orthopedic and Spine Center: https://www.bhosc.com/ About the Host: Meredith is the Co-founder and President of Grow Strong Leaders. Her company publishes software tools and books that help people build strong relationships at work and at home.Meredith is an expert in leader and team communications, the author of three books, and the host of the Grow Strong

Dr. Vivek Solanki from Polaris Healthcare Partners joins Matt this week on the Dentist Money Show to dive into the vital role clinical management plays in the success of dental practices. Sharing his experience, Dr. Solanki unpacks the impact of poor clinical leadership on both patient care and business outcomes. He talks about the balance dentists must find between clinical excellence and business strategy. Tune in to hear insights on the challenges of shifting practice culture and why collaboration and support are crucial to sustainable growth. Book a free consultation with a CFP® advisor who only works with dentists. Get an objective financial assessment and learn how Dentist Advisors can help you live your rich life.

Send us a textIn this episode of The Daily Apple, Dr. John Osborne and JD Enright from Clear Cardio join Kevin to talk about something that affects literally everyone with a heartbeat: heart disease. But instead of waiting until the heart attack hits, they're flipping the script and focusing on prevention—with a little help from cutting-edge AI.They dive into how artificial intelligence is changing the game in cardiac imaging, how to actually understand the difference between soft and hard plaque (yes, it matters), and why lifestyle changes aren't just good advice—they're lifesaving.

Gaps in cardiovascular care have sparked the need for a better solution. On this MedAxiom HeartTalk, host Melanie Lawson, MS, talks with Ben Peterson, MD, MPH, Interventional Cardiologist and Medical Director at Heart and Vascular Research Institute. They discuss the use of an AI tool to support patient identification and treatment needs, and envision a future of more personalized care.Watch the video here: https://hubs.li/Q03n-0Rb0

Pediatrician and holistic wellness expert Noemi Adame discusses her article, "Having a female doctor is better for your health, but not for hers." She highlights research indicating patients often experience better outcomes—including lower mortality, readmission, and post-surgical complication rates—when treated by female physicians, potentially linked to factors like longer visits and stronger adherence to guidelines. However, Noemi contrasts this with the significant personal toll on female doctors, who face higher burnout rates, a greater burden of uncompensated tasks like EMR messages (receiving 25 percent more requests), and a concerning lack of the longevity advantage seen in the general female population. She critiques the corporate medical system for failing to adequately support or compensate female physicians for the qualitative differences in their care delivery and the associated emotional labor. Noemi strongly advises female colleagues to protect their own well-being by considering alternatives to corporate employment, such as Direct Primary Care (DPC), independent contracting, or building a personal brand, while also acknowledging the unique challenges women face in setting boundaries within these models. Actionable takeaways emphasize the critical need for female physicians to prioritize self-care, implement sustainable practice systems, and advocate for themselves, whether inside or outside traditional employment structures. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Interview with Yu-Hsiang Wu, MD, PhD and Todd Ricketts, PhD, authors of Impact of Hearing Aid Service Model and Technology on Patient Outcomes:A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Hearing Aid Service Models, Technology, and Patient Outcomes

Episode DescriptionAudra Moran is the President and CEO of OCRA—Ovarian Cancer Research Alliance—which means she spends her days doing things most of us wouldn't survive five minutes doing: merging nonprofits, leading national patient support programs, funding lifesaving research, surviving pharma grant hell, and trying to reach every woman in America who might be slipping through the cracks. We talk about her time working with the Helen Keller National Center (yes, she knows finger spelling), her accidental journey into cancer nonprofit leadership, the weirdness of dermoid cysts, the ridiculousness of writing grants, and the absolute hellscape of diagnosis delay. Oh, and the fallopian tubes. You'll never look at them the same way again.This episode is funny, raw, deeply personal, and loaded with Gen X movie references and random facts about Paul Rudd, Terminator 2, and flipbook apps at 3am. Audra drops wisdom, humility, and a few hot takes on AI, advocacy, and what it really means to lead when the boulder keeps rolling downhill.RELATED LINKSAudra Moran on LinkedInOvarian Cancer Research Alliance (OCRA)Audra's profile on OCRACURE Today interview: Leading the FightOCRA + AI & Data: Overlooked PodcastFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Christine Verini is a pharmacist by training, a nonprofit CEO by title, and an unapologetic empath by design. She now leads CancerCare, one of the oldest, least-known, and most impactful organizations in the country that actually helps real cancer patients deal with the practical garbage no one likes to talk about—like paying rent, affording a ride to chemo, or feeding their kids.We talk about her career pivot from industry to impact, what it's like trying to scale empathy without losing your soul, and the daily gut-punch of knowing there are millions of people who still have no idea that CancerCare exists. Christine gets real about leadership, advocacy, burnout, and why being “pan-cancer” matters more than ever in a world obsessed with biomarkers, buckets, and branding.She also dishes on what AI gets dead wrong, what patients actually want when they call for help, and why “ghosting” someone with cancer is still a thing. Buckle up. This one's packed with heart, brains, and a little righteous rage.RELATED LINKSCancerCareChristine Verini on LinkedInChristine's CEO Announcement – PR NewswireCancer Health 25: Christine VeriniChristine on HealthyWomenBIO Convention Speaker ProfileFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Wearable health trackers are revolutionizing healthcare by providing continuous biometric data, improving patient care, and driving more informed health decisions. In this episode, Jason Oberfest, Vice President of Health Partnerships at ŌURA, discusses how the ŌURA Ring is transforming healthcare through its focus on sleep, readiness, and activity tracking. He highlights the potential for wearable health trackers to improve primary care, chronic care management, and women's health. Jason also explores partnerships with payers and providers, such as the collaboration with Essence Healthcare, to integrate wearable data into care plans and improve patient outcomes. Jason also emphasizes the importance of accuracy and scientific validation in wearable technology, ensuring that the data collected is reliable and actionable for both patients and healthcare professionals. Tune in and learn how wearable health trackers are shaping the future of healthcare! Resources: Connect with and follow Jason Oberfest on LinkedIn. Learn more about ŌURA on their LinkedIn and website.

Physical therapists often shy away from clinic retail, fearing they'll come off as "salesy." Paul Timko from Stop Pain Clinical joins us to explain why selling isn't sleazy — it's smart. Paul shares how smart retail strategies improve patient care, strengthen home exercise compliance, and even grow your clinic's revenue. Plus, learn about his Clinic Retail Mastermind and how it's helping PTs nationwide level up without selling out.In This Episode:Why PTs resist retail — and why they shouldn'tReal examples of retail boosting outcomesEasy ways to start offering products ethicallyWhat the Clinic Retail Mastermind is and how to joinWhy creativity is your clinic's superpowerResources:Learn more about the Clinic Retail Mastermind: https://stopa.in/mastermindContact Paul Timko: (440) 396-4361 (text or call)Learn more about Stop Pain Clinical: stopa.inConnect with PT Pintcast:Subscribe on Apple PodcastsFollow on SpotifySubscribe to PT Pintcast on YouTubeFollow Jimmy on LinkedInInstagram: @ptpintcastWebsite: ptpintcast.com

Jennifer Finkelstein is not here for your pity, your pinkwashed slogans, or your performative awareness campaigns. She's a 20-year young adult breast cancer survivor who turned trauma into a blueprint for action and built 5 Under 40, a no-BS nonprofit supporting women diagnosed with breast cancer under 40.In this episode, we go full Gen X therapy session—from SNL nostalgia and cold caps to the absurdity of finding out you have cancer while looking for the remote. Jen drops real talk about founding a nonprofit when nothing existed for her age group, why mental health support isn't optional, and how passing down designer scarves can mean arming someone for battle.If you're looking for honesty, grit, and a few inappropriate jokes about gastroenterology, this one's for you. You'll laugh, you might cry, and you'll definitely leave knowing why Jennifer Finkelstein is a survivor, a fighter, and a damn legend.RELATED LINKS5 Under 40 FoundationJennifer Finkelstein on LinkedInAbout 5 Under 40: Board of DirectorsDan's Papers: 5 Under 40 Supports Young Breast Cancer SurvivorsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.Let me know if you want shorter pull quotes, audiogram text, or promotional copy for LinkedIn, Instagram, or your newsletter.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What happens when a black belt, sword-slinging fitness icon gets cancer—twice? She picks up a camera and dares the universe to test her again.Ilaria Montagnani is not your average anything. She's been building strong bodies (and stronger minds) for over 30 years as the founder of Powerstrike. She's part Jane Fonda, part Uma Thurman, and very much the action hero you wish was your personal trainer.In this episode, we talk about what happens when everything you built your life on—movement, strength, purpose—gets sideswiped by disease. Twice. Ilaria opens up about diagnosis shock, bad doctor vibes, wielding swords post-mastectomy, and why working out through treatment is the best revenge.We get into scanxiety, menopause side effects, nutrition spirals, and the moment she realized the fitness industry needed more truth—and less bullshit.This one's real, raw, and will either guilt you into planking or inspire you to finally cancel that gym membership you've never used. Either way, you're gonna feel something.RELATED LINKSStronger for Life documentaryPowerstrike official siteIlaria on InstagramIlaria on LinkedInWorkout programs and DVDsForza Sword Workout on AmazonFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Jeff Langmaid dives into a groundbreaking 2025 study from Frontiers in Psychology that reveals how the context of your care—everything from your words and tone to the cleanliness of your practice—can dramatically influence patient outcomes in musculoskeletal pain. Dr. Jeff unpacks the powerful concept of “contextual effects,” which go far beyond the placebo and play a critical role in healing. He shares actionable clinical pearls on leveraging empathy, clarity, and positive expectations to drive better results for your patients.Episode Notes: Contextual effects in musculoskeletal pain: are we overlooking essential factors?The Best Objective Assessment of the Cervical Spine- Provide reliable assessments and exercises for Neuromuscular Control, Proprioception, Range of Motion, and Sensorimotor-Integration. Learn more at NeckCare.comTurncloud EHR- Minimalist design, without being sparse. Practical, yet elegant. Turncloud's design was to find the most efficient path in a day in the life of a chiropractic office. Connect with their team at www.turncloud.com Patient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

Helene M. Epstein is not here to make friends with the healthcare system. She's here to dismantle the bullshit, one catastrophic medical error at a time. A marketing agency veteran turned patient safety firebrand, Helene's journey from copywriter to cancer misdiagnosis survivor, to “badass queen of patient safety,” is one hell of a ride.We talk about how her son was misdiagnosed over 15 times (yes, really), why some doctors should come with warning labels, and how American healthcare gaslights patients like it's a competitive sport. She also explains why she's giving away her new book for free, one chapter at a time, and how AI might actually be useful—if it stops hallucinating citations.This is not a light listen. It's the real deal. You'll walk away angry, inspired, and a lot more dangerous as a patient.RELATED LINKSHelene's Substack: https://helenemepstein.substack.comPatient Safety Resources: https://www.pfps.usSociety to Improve Diagnosis in Medicine: https://psnet.ahrq.gov/issue/society-improve-diagnosis-medicineHelene's Website: https://www.hmepstein.com/meet-heleneLinkedIn: https://www.linkedin.com/in/hmepsteinFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform.For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jonathan and Jennifer Wall didn't choose this path, but they're walking it with purpose. After losing their son, Zach, they turned their grief into action, founding Zach's Bridge, a lifeline for families navigating pediatric cancer. This episode isn't about platitudes or silver linings—it's about the raw, unfiltered reality of love and loss, the relentless unfairness of childhood cancer, and how the Walls are refusing to let their son's memory fade into the void.Jon and Jenn open up about what Zach taught them, how they've reshaped their lives in his honor, and why “Be Like Zach” isn't just a phrase—it's a call to action. We talk about the power of community, the frustrating gaps in pediatric cancer care, and how they're making sure no other family has to walk this road alone. If you've ever wondered what real resilience looks like, this is it.RELATED LINKS:Zach's BridgeZach's Rules for LifeBe Like Zach - SubstackJonathan Wall on LinkedInJon's Post: What Cancer Taught Me About WorkRett's Roost Blog - Jonathan's WritingZach's Story - OSIFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sarah Armstrong—forever Sarah Oakden to me, no matter what the legal documents say—isn't just my best friend. She's my first college friend, my musical theater soulmate, and the first person who truly saw me as an artist. She was there when I walked onto Binghamton's campus, and she was there when I walked into cancer hell. And, because we're nothing if not in sync, a few decades later, she got her own cancer badge of honor, and I was right there with her every step of the way.This episode is a love letter to friendship, music, and those moments that change your life forever. We nerd out over Sondheim, Binghamton's infamous "Theater 101 with Dr. Susan Peters." and the weird and wonderful rabbit holes that turn into entire alternate realities across decades of aging gracefully and falling with style.We talk about how cancer is the worst club with the best people and how surviving it together just adds another verse to the song we've been singing for 30 years. It's funny. It's real. It's a master class in love, laughter, and musicals that should have been bigger; with a big tip of the hat to Nancy Ford and Gretchen Cryer for their acclaimed musical "I'm Getting My Act Together and Taking It on the Road"Oh, and RIP to the legendary Denny's on Vestal Parkway. You will be missed.FEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Family physician Pamela Buchanan discusses her article, "Why diversity in medicine saves lives." Pamela shares powerful stories from her career, like adjusting a biracial child's treatment for a scalp infection and saving a Black woman with sickle cell disease from misdiagnosis, to illustrate how diversity enhances patient care. She addresses systemic biases—such as the undertreatment of Black women's pain and misdiagnosis of women's heart attack symptoms—and backs her insights with research showing better outcomes with diverse physicians. Pamela urges health care professionals to embrace cultural competence and collaboration, offering a clear takeaway: Diverse perspectives in medicine are essential for reducing disparities and saving lives. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise and it's part of Microsoft Cloud for Healthcare–and it's built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended